Fermenta Biotech Share Price | Fermenta Biotech Stock Screener
FERMENTA
Pharmaceuticals
Share Price NSE
₹294.60
▲
6.95 (2.42%)
Share Price BSE
₹293.20
▲
2.60 (0.89%)
As of May 27, 2026, the Fermenta Biotech share price (NSE: FERMENTA) is ₹294.60 on NSE and ₹293.20 on BSE, up 2.42% from the previous close, with shares trading between ₹286.25 and ₹295.95, and a 52-week range of ₹281.00–₹322.35.
Check FERMENTA annual price range for the annual price range and momentum.
Use the Fermenta Biotech stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Fermenta Biotech Market Cap
₹867.04 Cr.
FERMENTA P/E Ratio (TTM)
10.07
Fermenta Biotech P/B Ratio
2.19
EPS (TTM)
₹26.35
Dividend Yield
1.26%
Debt to Equity
0.39
FERMENTA 52 Week High
₹322.35
Fermenta Biotech 52 Week Low
₹281.00
Operating Margin
16.00%
Profit Margin
13.97%
FERMENTA Revenue (TTM)
₹136.00
EBITDA
₹34.00
Net Income
₹19.00
Total Assets
₹648.00
Total Equity
₹406.00
Fermenta Biotech Share Price Chart
Screen Fermenta Biotech share price with an interactive chart. Analyse FERMENTA price trends and volatility across different timeframes.
Fermenta Biotech Company Profile - Fundamental Screener
Screen Fermenta Biotech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for FERMENTA shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE225B01021
Fermenta Biotech Balance Sheet Screener
Screen FERMENTA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 648 | 615 | 548 | 637 | 707 | 687 | 614 | 551 | 387 | 308 |
| Current Assets | 388 | 335 | 242 | 253 | 314 | 310 | 284 | 296 | 182 | 104 |
| Fixed Assets | 229 | 227 | 269 | 267 | 299 | 263 | 200 | 178 | 177 | 172 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 39 | 44 | 89 | 115 | 128 | 117 | 110 | 145 | 146 | 49 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 406 | 359 | 285 | 313 | 372 | 360 | 309 | 251 | 137 | 173 |
| Share Capital | 14 | 15 | 14 | 14 | 14 | 14 | 14 | 5 | 2 | 2 |
| Reserves & Surplus | 392 | 348 | 274 | 301 | 358 | 346 | 295 | 246 | 124 | 142 |
Fermenta Biotech Income Statement Screener - Profit & Revenue Analysis
Screen Fermenta Biotech income statement and profit fundamentals.
Analyze FERMENTA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Fermenta Biotech share price evaluation.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 136 | 144 | 145 | 136 | 141 | 103 | 81 | 98 | 159 | 106 | 85 | 59 | 102 | 99 | 96 |
| Expenses | 102 | 103 | 108 | 104 | 115 | 92 | 77 | 76 | 103 | 95 | 72 | 78 | 74 | 78 | 87 |
| EBITDA | 34 | 41 | 37 | 32 | 26 | 11 | 4 | 22 | 56 | 11 | 13 | -19 | 28 | 21 | 9 |
| Operating Profit % | 16.00% | 26.00% | 21.00% | 20.00% | 17.00% | 6.00% | 1.00% | 20.00% | 34.00% | 10.00% | 13.00% | -38.00% | 25.00% | 18.00% | 5.00% |
| Depreciation | 5 | 6 | 6 | 5 | 5 | 7 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 |
| Interest | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 6 | 5 | 4 | 5 | 4 | 5 |
| Profit Before Tax | 26 | 32 | 28 | 24 | 18 | 1 | -6 | 12 | 45 | -1 | 2 | -29 | 16 | 10 | -2 |
| Tax | 8 | -1 | 7 | 6 | 6 | 8 | 0 | 1 | 8 | 4 | 0 | 0 | 6 | 2 | 0 |
| Net Profit | 19 | 33 | 22 | 18 | 12 | -7 | -6 | 11 | 38 | -5 | 2 | -29 | 10 | 8 | -3 |
| EPS | 6.66 | 11.79 | 7.49 | 6.20 | 4.36 | -2.41 | -2.01 | 3.94 | 12.71 | -1.42 | 0.64 | -7.32 | 3.41 | 2.66 | -0.90 |
Fermenta Biotech Cash Flow Screener - Liquidity Fundamentals
Screen FERMENTA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 41 | 105 | 116 | 43 | 63 | 35 | 90 | 59 | 2 | 4 |
| Investing Activities | 0 | -16 | -55 | -26 | -41 | -44 | -97 | -101 | 7 | -13 |
| Financing Activities | -51 | -91 | -41 | -22 | -1 | -48 | 12 | 89 | -12 | 10 |
| Net Cash Flow | -10 | -1 | 19 | -4 | 21 | -57 | 6 | 47 | -4 | 2 |
Fermenta Biotech Shareholding Pattern Screener
See Fermenta Biotech shareholding pattern with promoter, FII, and DII holdings.
Check Fermenta Biotech promoter holding and ownership changes for FERMENTA on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 64.09% | 64.09% | 64.09% | 64.09% | 64.09% | 62.06% | 62.06% | 62.06% |
| FII Holding | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.00% | 0.00% | 0.05% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 28.80% | 30.38% | 29.60% | 29.76% | 29.48% | 32.47% | 32.51% | 31.29% |
| Other Holding | 7.09% | 5.51% | 6.29% | 6.12% | 6.41% | 5.47% | 5.43% | 6.59% |
| Shareholder Count | 13,661 | 12,930 | 12,845 | 13,760 | 14,139 | 15,178 | 14,589 | 13,221 |
Fermenta Biotech Share Dividend Screener - Share Yield Analysis
Check Fermenta Biotech dividend history with payout and yield data.
View Fermenta Biotech dividend details including ex-dates and amounts for FERMENTA stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹2.50 | 0.78% |
| 2024-March | ₹1.25 | 0.46% |
| 2023-March | ₹1.25 | 0.83% |
| 2022-March | ₹1.25 | 1.12% |
| 2021-March | ₹2.50 | 1.22% |
| 2020-March | ₹5.00 | 2.00% |
| 2019-March | ₹1.25 | 0.59% |
| 2018-March | ₹2.50 | 0.91% |
| 2017-March | ₹2.50 | 1.05% |
Fermenta Biotech Stock Index Membership
See which indices include Fermenta Biotech stock.
Check FERMENTA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Fermenta Biotech Market Events Screener - Corporate Actions
Get Fermenta Biotech corporate actions including splits, bonuses, and buybacks.
Check Fermenta Biotech stock events that may affect FERMENTA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 1.25 /share | 19.56% | ||
| Extraordinary General Meeting | NA | -5.20% | ||
| 2026-05-26 | 2026-05-26 | Quarterly Result Announcement | NA | 5.55% |
| 2026-02-09 | 2026-02-09 | Quarterly Result Announcement | NA | -0.20% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | 3.74% |
| 2025-08-12 | 2025-08-12 | Annual General Meeting | NA | 17.70% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -2.81% |
| 2025-08-06 | 2025-08-06 | Dividend | ₹ 2.50 /share | 22.43% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | -1.97% |
| 2025-02-11 | 2025-02-11 | Quarterly Result Announcement | NA | 11.80% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -5.12% |
| 2024-08-12 | 2024-08-12 | Annual General Meeting | NA | 52.13% |
| 2024-08-06 | 2024-08-06 | Dividend | ₹ 1.25 /share | 46.02% |
| 2022-08-04 | 2022-08-05 | Dividend | ₹ 1.25 /share | -3.77% |
| 2021-08-25 | 2021-08-27 | Dividend | ₹ 2.50 /share | -12.85% |
Fermenta Biotech Competitors Screener - Peer Comparison
Screen FERMENTA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 442,509 | 38.37 | 58,220 | 6.38% | 11,565 | 54.66 |
| Divis Laboratories | 180,452 | 69.82 | 10,560 | 8.73% | 2,520 | 59.28 |
| Torrent Pharmaceuticals | 153,580 | 70.46 | 13,753 | 19.18% | 2,028 | 60.91 |
| Cipla | 114,559 | 29.64 | 27,712 | -2.46% | 3,783 | 64.86 |
| Dr Reddys Laboratories | 110,089 | 26.69 | 33,593 | -0.44% | 3,998 | 54.22 |
| Zydus Life Science | 109,257 | 21.19 | 26,720 | 13.65% | 5,242 | 75.42 |
| Lupin | 104,041 | 19.33 | 27,488 | 19.98% | 5,345 | 46.91 |
| Mankind Pharma | 99,915 | 51.52 | 14,278 | 12.03% | 1,750 | 55.29 |
| Aurobindo Pharma | 83,397 | 24.27 | 33,385 | 3.21% | 3,376 | 47.24 |
| Laurus Labs | 74,592 | 83.31 | 6,813 | 21.03% | 884 | 80.70 |
Fermenta Biotech Company Announcements - News Screener
Screen FERMENTA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| Announcement under Regulation 30 (LODR)-Newspaper Publication | - | |
| 2026-05-28 | Corporate Action-Board approves Dividend | - |
| 2026-05-28 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-05-28 | Intimation Under Regulation 30 And Other Applicable Provisions Of SEBI Listing Regulations | - |
| 2026-05-28 | Board Meeting Outcome for Annual General Meeting Financial Results And Dividend | - |
| 2026-05-28 | Audited Financial Statements (Standalone And Consolidated) For Quarter & Year Ended March 31 2026 Along With Auditors Report Thereon Along With Information For AGM And Dividend | - |
| 2026-05-27 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-21 | Board Meeting Intimation for Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2026 And Consideration Of Final Equity Dividend If Any. | - |
| 2026-05-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-04-28 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-04-28 | Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 | - |
| 2026-04-28 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-21 | Admission Of Companys Shares By NSE Under Permitted To Trade Category On National Stock Exchange (Capital Market Segment). | - |
| 2026-04-15 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-31 | Closure of Trading Window | - |
| 2026-02-28 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-19 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-02-11 | Intimation Of Investor Presentation - Q3/9Mofy26 | - |
| 2026-02-10 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-09 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |